Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caprius(CAPR), Breast MRI(former ANMR/MAMO) -- Ignore unavailable to you. Want to Upgrade?

To: Roland Chen who wrote (2087)	11/7/1997 8:00:00 PM
From: Sean Reilly	Read Replies (1) \| Respond to of 2615

Roland, Did you read the Nasdaq release like 2 weeks ago ? It stated that if the merger failed they would be delisted. In the proxy it stated that if the merger failed to go thru MAMO ends up in bankruptcy and ANMR as a debtor gets its share of the assets. It'll go thru, trust me. ...Sean

To: Roland Chen who wrote (2087)	11/9/1997 11:26:00 AM
From: Zeev Hed	Read Replies (1) \| Respond to of 2615

Roland, I have been down at the FONR thread for the last few days trying to understand why their stock has not moved despite the finality of the GE settlement. I was wondering why they do not discuss ANMR/MAMO impact on the planned entry into mamography of this outfit and why no posts here (at least the last 100 posts I perused) address this competitive threat. Can you shed light on this issue for me? By the way, did GE actually acquire the high field business completely and paid just $5.1 for which they will eventually get some 20 MM shares or more (and will own 25% of ANMR) or have I missed another payment associated with that acquisition? TIA. Zeev